Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

被引：0

作者：

Rogado, J. ^{[1
]}

Pacheco-Barcia, V. ^{[1
]}

Fenor De la Maza, M. D. ^{[1
]}

Serra, J. M. ^{[2
]}

Toquero, P. ^{[1
]}

Vera, B. ^{[1
]}

Obispo, B. ^{[1
]}

Mondejar, R. ^{[1
]}

Ballesteros, A. ^{[1
]}

Donnay, O. ^{[1
]}

Colomer, R. ^{[1
]}

Sanchez-Torres, J. M. ^{[1
]}

机构：

[1] Hosp Univ La Princesa, Oncol Med, Madrid, Spain

[2] Hosp Univ La Princesa, Farm Dept, Madrid, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

anti PD-1; Nivolumab; Non-small-cell lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.01-057

引用

页码：S1915 / S1916

页数：2

共 50 条

[21] The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
Huang, Jiaxing
Zhang, Yaxiong
Sheng, Jin
Zhang, Hongyu
Fang, Wenfeng
Zhan, Jianhua
Zhou, Ting
Chen, Ying
Liu, Lin
Zhang, Li
[J]. ONCOTARGETS AND THERAPY, 2016, 9 : 5867 - 5874
[22] Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer
Gerber, David E.
Spigel, David R.
Giorgadze, David
Shtivelband, Mikhail
Ponomarova, Olga V.
Shan, Joseph S.
Menander, Kerstin B.
Belani, Chandra P.
[J]. CLINICAL LUNG CANCER, 2016, 17 (03) : 169 - 176
[23] NIVOLUMAB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): SURVIVAL AND CLINICAL ACTIVITY BY SUBGROUP ANALYSIS
Brahmer, Julie R.
Horn, Leora
Gandhi, Leena
Spigel, David R.
Antonia, Scott J.
Rizvi, Naiyer A.
Powderly, John D.
Heist, Rebecca S.
Carvajal, Richard D.
Jackman, David M.
Sequist, Lecia V.
Smith, David C.
Leming, Philip D.
Topalian, Suzanne L.
Hodi, Stephen
Snzol, Mario
Harbison, Christopher T.
Kollia, Gerogia D.
Gupta, Ashok
Gettinger, Scott N.
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 157 - 157
[24] Nivolumab after Progression to Platinum- Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Lopez Flores, M.
Diz Tain, P.
Delgado Sillero, I.
Sanchez Cousido, L.
Lopez Gonzalez, A.
Pedraza Lorenzo, M.
Rodriguez Sanchez, A.
Castanon Lopez, C.
Nieto Mangudo, B.
Garcia Casabal, F.
De Sande Gonzalez, L.
Garcia Palomo, A.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1916 - S1917
[25] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
Mielgo, X.
Toro, P.
Ruiz-Gimenez, L.
Olier, C.
Perez, M.
Rosero, A.
Camara, J. C.
Hernando, S.
Hurtado, A.
Jara, C.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
[26] Role of Crizotinib in previously treated non-small-cell lung cancer
Gupta, Sunil Kumar
[J]. SOUTH ASIAN JOURNAL OF CANCER, 2014, 3 (02) : 138 - 140
[27] Paclitaxel cisplatin in advanced non-small-cell lung cancer (NSCLC)
Pirker, R
Krajnik, G
Zochbauer, S
Malayeri, R
Kneussl, M
Huber, H
[J]. ANNALS OF ONCOLOGY, 1995, 6 (08) : 833 - 835
[28] EXPOSURE- RESPONSE (E-R) ANALYSIS OF OVERALL SURVIVAL (OS) FOR NIVOLUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC).
Feng, Y.
Bajaj, G.
Agrawal, S.
Wang, X.
Bello, A.
Roy, A.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S7 - S7
[29] EXPOSURE-RESPONSE (E-R) ANALYSIS OF OVERALL SURVIVAL (OS) FOR NIVOLUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC)
Feng, Y.
Bajaj, G.
Agrawal, S.
Wang, X.
Bello, A.
Roy, A.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S56 - S57
[30] Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression
Ricciuti, Biagio
Genova, Carlo
Bassanelli, Maria
De Giglio, Andrea
Brambilla, Marta
Metro, Giulio
Baglivo, Sara
Dal Bello, Maria Giovanna
Ceribelli, Anna
Grossi, Francesco
Chiari, Rita
[J]. CLINICAL LUNG CANCER, 2019, 20 (03) : 178 - +

← 1 2 3 4 5 →